Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma (Q33964077)

30 July 2017

0 references

1 reference

title

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma (English)

1 reference

30 July 2017

0 references

1 reference

L Tiong

1

1 reference

PubMed ID

21766289

30 July 2017

G J Maddern

series ordinal

2

1 reference

PubMed ID

21766289

30 July 2017

language of work or name

English

0 references

publication date

15 July 2011

1 reference

British Journal of Surgery

30 July 2017

1 reference

30 July 2017

98

1 reference

30 July 2017

9

1 reference

30 July 2017

1210-1224

1 reference

The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.

30 July 2017

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Hepatocellular carcinoma: an epidemiologic view

21 January 2018

1 reference

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Actual role of radiofrequency ablation of liver metastases

21 January 2018

1 reference

21 January 2018

Metastatic liver tumors

1 reference

Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial

21 January 2018

1 reference

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

21 January 2018

1 reference

High-power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex vivo and porcine in vivo settings.

21 January 2018

1 reference

Comparison of wet radiofrequency ablation with dry radiofrequency ablation and radiofrequency ablation using hypertonic saline preinjection: ex vivo bovine liver

21 January 2018

1 reference

Bipolar radiofrequency ablation using wet-cooled electrodes: an in vitro experimental study in bovine liver.

21 January 2018

1 reference

Hepatic radiofrequency ablation.

21 January 2018

1 reference

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

21 January 2018

1 reference

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode

21 January 2018

1 reference

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

21 January 2018

1 reference

Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results.

21 January 2018

1 reference

Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial

21 January 2018

1 reference

Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC

21 January 2018

1 reference

Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver

21 January 2018

1 reference

Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.

21 January 2018

1 reference

Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes

21 January 2018

1 reference

Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients

21 January 2018

1 reference

Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study

21 January 2018

1 reference

Radiofrequency ablation for hepatocellular carcinoma: a prospective comparison of four radiofrequency devices.

21 January 2018

1 reference

Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?

21 January 2018

1 reference

Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.

21 January 2018

1 reference

Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis.

21 January 2018

1 reference

Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.

21 January 2018

1 reference

Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy

21 January 2018

1 reference

Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas

21 January 2018

1 reference

Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.

21 January 2018

1 reference

Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment.

21 January 2018

1 reference

A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.

21 January 2018

1 reference

Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.

21 January 2018

1 reference

Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.

21 January 2018

1 reference

Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy

21 January 2018

1 reference

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

21 January 2018

1 reference

Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results

21 January 2018

1 reference

Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures

21 January 2018

1 reference

Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications

21 January 2018

1 reference

Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation.

21 January 2018

1 reference

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

21 January 2018

1 reference

Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation

21 January 2018

1 reference

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy

21 January 2018

1 reference

Waiting list removal rates among patients with chronic and malignant liver diseases.

21 January 2018

1 reference

Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list

21 January 2018

1 reference

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

21 January 2018

1 reference

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

21 January 2018

1 reference

An analysis of 412 cases of hepatocellular carcinoma at a Western center

21 January 2018

1 reference

Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence.

21 January 2018

1 reference

Report of the 18th follow-up survey of primary liver cancer in Japan

21 January 2018

1 reference

Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial

21 January 2018

1 reference

Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation

21 January 2018

1 reference

Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BJS.7669

1 reference

30 July 2017

1 reference

PubMed ID

21766289